These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis. Lu HK; Chen YL; Chang HC; Li CL; Kuo MY J Periodontal Res; 2006 Aug; 41(4):354-60. PubMed ID: 16827732 [TBL] [Abstract][Full Text] [Related]
6. The expression levels of MicroRNA-146a, RANKL and OPG after non-surgical periodontal treatment. Sattari M; Taheri RA; ArefNezhad R; Motedayyen H BMC Oral Health; 2021 Oct; 21(1):523. PubMed ID: 34645448 [TBL] [Abstract][Full Text] [Related]
7. Expression of RANKL and OPG mRNA in periodontal disease: possible involvement in bone destruction. Liu D; Xu JK; Figliomeni L; Huang L; Pavlos NJ; Rogers M; Tan A; Price P; Zheng MH Int J Mol Med; 2003 Jan; 11(1):17-21. PubMed ID: 12469211 [TBL] [Abstract][Full Text] [Related]
8. Leptin regulates OPG and RANKL expression in Gingival Fibroblasts and Tissues of Chronic Periodontitis Patients. Guo Y; Xu C; Wu X; Zhang W; Sun Y; Shrestha A Int J Med Sci; 2021; 18(11):2431-2437. PubMed ID: 33967621 [No Abstract] [Full Text] [Related]
9. The relationship between T-helper cell polarization and the RANKL/OPG ratio in gingival tissues from chronic periodontitis patients. Bi CS; Sun LJ; Qu HL; Chen F; Tian BM; Chen FM Clin Exp Dent Res; 2019 Aug; 5(4):377-388. PubMed ID: 31944625 [TBL] [Abstract][Full Text] [Related]
10. LPS-stimulated human gingival fibroblasts inhibit the differentiation of monocytes into osteoclasts through the production of osteoprotegerin. Nagasawa T; Kobayashi H; Kiji M; Aramaki M; Mahanonda R; Kojima T; Murakami Y; Saito M; Morotome Y; Ishikawa I Clin Exp Immunol; 2002 Nov; 130(2):338-44. PubMed ID: 12390325 [TBL] [Abstract][Full Text] [Related]
11. Emerging roles of Interleukin-34 together with receptor activator of nuclear factor-kB ligand and osteoprotegerin levels in periodontal disease. Bozkurt Doğan Ş; Öngöz Dede F; Ballı U; Sertoğlu E Cytokine; 2021 Aug; 144():155584. PubMed ID: 34034144 [TBL] [Abstract][Full Text] [Related]
12. [Effects of chitosan oligosaccharide on alveolar bone resorption, Th17/Treg balance and OPG/RANKL/RANK pathway in periodontitis rats]. Zhang L; Liu YS; Wu YF; Fu QY Shanghai Kou Qiang Yi Xue; 2021 Jun; 30(3):237-242. PubMed ID: 34476437 [TBL] [Abstract][Full Text] [Related]
13. Effects of Enterococcus faecalis lipoteichoic acid on receptor activator of nuclear factor-κB ligand and osteoprotegerin expression in periodontal ligament fibroblasts. Zhao L; Chen J; Cheng L; Wang X; Du J; Wang F; Peng Z Int Endod J; 2014 Feb; 47(2):163-72. PubMed ID: 23710898 [TBL] [Abstract][Full Text] [Related]
14. Differential expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin mRNA in periodontal diseases. Bostanci N; Ilgenli T; Emingil G; Afacan B; Han B; Töz H; Berdeli A; Atilla G; McKay IJ; Hughes FJ; Belibasakis GN J Periodontal Res; 2007 Aug; 42(4):287-93. PubMed ID: 17559623 [TBL] [Abstract][Full Text] [Related]
15. Expression and Distribution of Receptor Activator of Nuclear Factor Kappa B, Receptor Activator of Nuclear Factor Kappa B Ligand, and Osteoprotegerin in Periradicular Cysts. Armada L; Marotta Pdos S; Pires FR; Siqueira JF J Endod; 2015 Aug; 41(8):1281-7. PubMed ID: 25956608 [TBL] [Abstract][Full Text] [Related]
16. Expression profile of osteoprotegerin, RANK and RANKL genes in the femoral head of patients with avascular necrosis. Samara S; Dailiana Z; Chassanidis C; Koromila T; Papatheodorou L; Malizos KN; Kollia P Exp Mol Pathol; 2014 Feb; 96(1):9-14. PubMed ID: 24200492 [TBL] [Abstract][Full Text] [Related]
17. Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio. Bostanci N; Ilgenli T; Emingil G; Afacan B; Han B; Töz H; Atilla G; Hughes FJ; Belibasakis GN J Clin Periodontol; 2007 May; 34(5):370-6. PubMed ID: 17355365 [TBL] [Abstract][Full Text] [Related]
18. Substance P participates in periodontitis by upregulating HIF-1α and RANKL/OPG ratio. Yan K; Lin Q; Tang K; Liu S; Du Y; Yu X; Li S BMC Oral Health; 2020 Jan; 20(1):27. PubMed ID: 32000757 [TBL] [Abstract][Full Text] [Related]
19. The RANKL-OPG system in clinical periodontology. Belibasakis GN; Bostanci N J Clin Periodontol; 2012 Mar; 39(3):239-48. PubMed ID: 22092994 [TBL] [Abstract][Full Text] [Related]
20. Assessment of Salivary Levels of RANKL and OPG in Aggressive versus Chronic Periodontitis. Teodorescu AC; Martu I; Teslaru S; Kappenberg-Nitescu DC; Goriuc A; Luchian I; Martu MA; Solomon SM; Mârțu S J Immunol Res; 2019; 2019():6195258. PubMed ID: 31183390 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]